We are live on
!
Find out more
JA
JVL Associates Portfolio holdings
AUM
$352M
1-Year Est. Return
27.55%
This Fund
S&P 500
This Quarter
Est. Return
+6.69%
1 Year Est. Return
+27.55%
3 Year Est. Return
+73.28%
5 Year Est. Return
+74.3%
10 Year Est. Return
–
AUM
$135M
AUM Growth
+$9.3M
(+7.4%)
Cap. Flow
+$1.49M
Cap. Flow
% of AUM
1.11%
Top 10 Holdings %
Top 10 Hldgs %
78.92%
Holding
38
New
1
Increased
13
Reduced
7
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$737K |
| 2 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$242K |
| 3 |
SPDR Gold Trust
GLD
|
+$203K |
| 4 |
TLND
Talend S.A. American Depositary Shares
TLND
|
+$186K |
| 5 |
Invesco QQQ Trust
QQQ
|
+$93K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$47.3K |
| 2 |
Uber
UBER
|
+$37.9K |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$34.7K |
| 4 |
ZOM
Zomedica Corp.
ZOM
|
+$13K |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$7.89K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.05% |
| 2 | Consumer Discretionary | 2.87% |
| 3 | Communication Services | 2.03% |
| 4 | Financials | 1.66% |
| 5 | Healthcare | 0.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Gentex
GNTX
$5.08B
| $713K | 0.53% |
20,000
| – | – |
|
|
27
Vanguard FTSE Developed Markets ETF
VEA
$234B
| $602K | 0.45% |
12,257
-969
| -7% | -$47.3K |
|
28
State Street SPDR S&P 500 ETF Trust
SPY
$819B
| $477K | 0.35% |
1,204
-7
| -0.6% | -$2.7K |
|
|
MCBC
29
DELISTED
Macatawa Bank Corp
MCBC
| $468K | 0.35% |
47,000
+1,000
| +2% | +$9.19K |
|
30
Medtronic
MDT
$110B
| $444K | 0.33% |
3,759
+35
| +0.9% | +$4.1K |
|
31
Novartis
NVS
$294B
| $418K | 0.31% |
4,895
| – | – |
|
32
Berkshire Hathaway Class A
BRK.A
$1.12T
| $386K | 0.29% |
1
| – | – |
|
33
Microsoft
MSFT
$3.62T
| $307K | 0.23% |
1,302
+20
| +2% | +$4.64K |
|
34
Amazon
AMZN
$2.94T
| $275K | 0.2% |
1,780
+360
| +25% | +$57.1K |
|
35
Asana
ASAN
$2.05B
| $229K | 0.17% |
8,020
| – | – |
|
|
TLND
36
DELISTED
Talend S.A. American Depositary Shares
TLND
| $227K | 0.17% |
+3,570
| New | +$186K |
|
|
RESN
37
DELISTED
Resonant Inc.
RESN
| $64K | 0.05% |
15,000
| – | – |
|
|
ZOM
38
DELISTED
Zomedica Corp.
ZOM
| – | – |
-58,500
| Closed | -$13K |
|
Similar funds
MCMU
FWM
EC
BL
PIC
ACA
OBGC
HIA
JVL Associates's Q1 2021 Portfolio in Review
As of Q1 2021, JVL Associates held 38 positions worth $135M, up 7.4% from $126M the previous quarter. Its ten largest holdings account for 79% of the portfolio.
JVL Associates's Q1 2021 filing shows 1 new, 13 increased, 7 reduced and 1 closed positions. Its largest new stake was Talend S.A. American Depositary Shares: 3,570 shares worth $227K. The largest sale was Vanguard FTSE Developed Markets ETF, an estimated $47.3K.
By sector, the portfolio is most concentrated in Technology at 7.1% of assets, down from 7.7% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- JVL Associates's largest Q1 2021 buy was Talend S.A. American Depositary Shares: 3,570 shares worth $227K.
- JVL Associates added most to iShares Core S&P Total US Stock Market ETF in Q1 2021, an estimated $737K increase.
- JVL Associates's biggest Q1 2021 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $47.3K.
- JVL Associates fully exited Zomedica Corp. in Q1 2021, selling an estimated $13K.
- JVL Associates's ten largest holdings make up 79% of its $135M portfolio in Q1 2021.
- JVL Associates opened 1 new position and closed 1 in Q1 2021.
- JVL Associates's portfolio value rose 7.4% quarter-over-quarter to $135M.
Based on JVL Associates's 13F filing for Q1 2021, filed 8 Mar 2022.